Information:
Fel:
ID
19436
Beskrivning
Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00451620
Länk
https://clinicaltrials.gov/show/NCT00451620
Nyckelord
Versioner (1)
- 2017-01-02 2017-01-02 -
Uppladdad den
2 januari 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Type 2 Diabetes NCT00451620
Eligibility Type 2 Diabetes NCT00451620
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes NCT00451620
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Non-Insulin-Dependent Diabetes Mellitus disease length
Item
type 2 diabetes > 3 months duration
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0872146 (UMLS CUI [1,2])
Gender
Item
male or female
boolean
C0079399 (UMLS CUI [1])
Age
Item
over 65 years of age
boolean
C0001779 (UMLS CUI [1])
Dietary control
Item
diet controlled only
boolean
C0743195 (UMLS CUI [1])
Glucohemoglobin measurement
Item
hgba1c < 8.5%
boolean
C0202054 (UMLS CUI [1])
Oral hypoglycemic | Insulin regime
Item
treatment with oral hypoglycemic agents or insulin or the likelihood of requiring treatment with these during the study.
boolean
C0359086 (UMLS CUI [1])
C0557978 (UMLS CUI [2])
C0557978 (UMLS CUI [2])
Anemia | Hemoglobin measurement | Gender
Item
anemia - hgb below 130 g/l (males) and below 120 g/l (females).
boolean
C0002871 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
C0518015 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Pharmaceutical Preparations Interfere with glucose metabolism | CORTICOSTEROIDS FOR SYSTEMIC USE | Non-selective beta-blocking agent
Item
taking medications that known to interfere with glucose metabolism eg systemic corticosteriods, non-selective beta blockers.
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
C3653708 (UMLS CUI [2])
C0304515 (UMLS CUI [3])
C0521102 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
C3653708 (UMLS CUI [2])
C0304515 (UMLS CUI [3])
Hypersensitivity Glyburide | Allergy to sulfonamides | Hypersensitivity NovoNorm | Liver Dysfunction | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
known or suspected allergy to glyburide, sulfa drugs or gluconorm impaired liver function, as shown by but not limited to ast and/or alt > 2x the upper limit of normal.
boolean
C0020517 (UMLS CUI [1,1])
C0017628 (UMLS CUI [1,2])
C0038757 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0732644 (UMLS CUI [3,2])
C0086565 (UMLS CUI [4])
C0151904 (UMLS CUI [5])
C0151905 (UMLS CUI [6])
C0017628 (UMLS CUI [1,2])
C0038757 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0732644 (UMLS CUI [3,2])
C0086565 (UMLS CUI [4])
C0151904 (UMLS CUI [5])
C0151905 (UMLS CUI [6])
Renal Insufficiency | Creatinine measurement, serum | Gender
Item
impaired renal function, as shown by but not limited to serum creatinine > 133 µmol/l (males) or 124 µmol/l (females).
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
C0201976 (UMLS CUI [2])
C0079399 (UMLS CUI [3])
Study Subject Participation Status
Item
participated in another clinical trial within the past 30 days.
boolean
C2348568 (UMLS CUI [1])